German healthcare industry sets sights on integrated care
This article was originally published in Clinica
Executive Summary
The introduction of the German diagnosis related groups (DRG) system for hospital reimbursement will intensify the need for integrated care procedures. This was the universal sentiment expressed by delegates to the medical device industry association BVMed's special conference on integrated care held last week in Mainz. The DRG system will reduce the average length of hospital stay and would consequently place added pressure on the ambulatory sector, including home care, experts said.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.